The impact of HCV eradication using interferon-free direct acting antivirals on bone-mineral, anemia parameters and peripheral insulin resistance in hepatitis c-infected Egyptian hemodialysis cohort

Bibliographic Information
Authors: Elnokeety M.M.; Darwish R.A.; Hegazy M.T.; Abouzeid S.; Fayed A.
Journal: Renal Replacement Therapy
Publisher: BioMed Central Ltd
Publication Date: 1 October 2023
Volume / Issue: Volume 9 / Issue 1
Article No.: 49
ISSN: 20591381
DOI: 10.1186/s41100-023-00500-4
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Elnokeety M.M., Nephrology Unit, Department of Internal Medicine, Faculty of Medicine, Cairo University, Al-Saray St., El-Maniel, Cairo, 11562, Egypt; Darwish R.A., Nephrology Unit, Department of Internal Medicine, Faculty of Medicine, Cairo University, Al-Saray St., El-Maniel, Cairo, 11562, Egypt; Hegazy M.T., Rheumatology and Clinical Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Cairo University, Al-Saray St., El-Maniel, Cairo, 11562, Egypt, Rheumatology and Clinical Immunology Unit, Department of Internal Medicine, Faculty of Medicine, New Giza University (NGU), Giza, Egypt; Abouzeid S., Nephrology Department, Theodor Bilharz Research Institute, Cairo, Egypt; Fayed A., Nephrology Unit, Department of Internal Medicine, Faculty of Medicine, Cairo University, Al-Saray St., El-Maniel, Cairo, 11562, Egypt
Abstract
Background: Hepatitis C virus (HCV) infection is linked to a higher mortality rate in hemodialysis (HD) patients. We aimed to see if HCV eradication using interferon-free direct acting antivirals (DAAs) can affect bone-mineral and anemia biochemical parameters such as serum calcium (Ca++), phosphorus (PO4+), parathormone (PTH), fibroblast growth factor 23 (FGF23), hemoglobin (HB), and ferritin in HD patients and also peripheral insulin resistance by monitoring serum fasting insulin and HOMA insulin resistance (HOMA-IR). Methods: Three hundred and thirty-four adults on regular HD with positive HCV genotype 4 (191 male and 143 female) were included; 157 of them had seroconversion during HD. All were hepatitis B virus (HBV) negative and received treatment with DAAs. All cases were examined for body mass index (BMI), HB, ferritin level, transferrin saturation (TSAT), Ca++, PO4+, PTH, FGF23, serum albumin, alanine transaminase (ALT), fasting insulin level, and HOMA-IR at the beginning and then were measured after 6 and 12 months from a sustained virological response (SVR). Results: After 6 and 12 months from SVR, there was a significant increase in serum Ca despite no change in oral calcium dose requirement over that period (p = 0001), a significant increase in HB, serum iron (p = 0001), and a significant reduction in serum ferritin, PO4, PTH, and FGF23 (p = 0001). Both fasting insulin level and HOMA-IR were statistically significantly dropped. Conclusion: HCV eradication with interferon-free DAAs showed a statistically significant impact on hemodialysis patients regarding hemoglobin, ferritin level, bone-mineral parameters, and improvement in peripheral insulin resistance. © 2023, The Japanese Society for Dialysis Therapy and BioMed Central Ltd.
Keywords
DAAs; FGF23; HCV; Hemodialysis; Insulin resistance; Parathormone
Citation Information
Scopus Citations: 2
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
